Firefly Neuroscience (AIFF) Return on Sales (2010 - 2026)

Firefly Neuroscience has reported Return on Sales for 16 years, with the latest figure at 0.04% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales rose 297.0% year-over-year to 0.04%; the trailing twelve-month figure through Mar 2026 stood at 0.06% (up 170.0% YoY), and the FY2025 full-year result was 0.17%, up 79.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.04%, up from 0.06% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q2 2022, with the low at 3.01% in Q1 2025.
• Average Return on Sales over 5 years is 0.33%, with a median of 0.03% recorded in 2026.
• Year-over-year, Return on Sales tumbled 129 bps in 2024 and soared 297 bps in 2026.
• Tracing AIFF's Return on Sales over 5 years: stood at 0.04% in 2022, then jumped by 101 bps to 0.0% in 2023, then slumped by 481762 bps to 1.3% in 2024, then jumped by 95 bps to 0.06% in 2025, then jumped by 31 bps to 0.04% in 2026.
• The last three Return on Sales figures came in at 0.04% (Q1 2026), 0.06% (Q4 2025), and 0.07% (Q3 2025), per Business Quant data.

Peer Comparison